TSNI Stock Overview
TechniScan, Inc., a development stage company, engages in the research, development, and commercialization of non-invasive medical imaging products for the detection and diagnosis of breast cancer.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
TechniScan, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -98.53% |
| 5 Year Change | -95.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| TSNI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | n/a | -3.7% | 19.3% |
Return vs Industry: Insufficient data to determine how TSNI performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how TSNI performed against the US Market.
Price Volatility
| TSNI volatility | |
|---|---|
| TSNI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TSNI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TSNI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | David Robinson | n/a |
TechniScan, Inc., a development stage company, engages in the research, development, and commercialization of non-invasive medical imaging products for the detection and diagnosis of breast cancer. It intends to develop the Warm Bath Ultrasound system, an ultrasound-based imaging device that provides radiologists with information about the bulk properties of tissue in the breast, as well as images of the tissue structure. The company is based in Salt Lake City, Utah.
TechniScan, Inc. Fundamentals Summary
| TSNI fundamental statistics | |
|---|---|
| Market cap | US$2.35k |
| Earnings (TTM) | -US$5.35m |
| Revenue (TTM) | US$376.61k |
0.0x
P/S Ratio0.0x
P/E RatioIs TSNI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSNI income statement (TTM) | |
|---|---|
| Revenue | US$376.61k |
| Cost of Revenue | US$139.04k |
| Gross Profit | US$237.57k |
| Other Expenses | US$5.58m |
| Earnings | -US$5.35m |
Last Reported Earnings
Dec 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TSNI perform over the long term?
See historical performance and comparison